+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Peanut Allergy Global Clinical Trials Review, H1, 2020

  • ID: 5004203
  • Clinical Trials
  • February 2020
  • Region: Global
  • 86 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Aimmune Therapeutics Inc
  • AnaptysBio Inc
  • Aravax Pty Ltd
  • Astellas Pharma Inc
  • DBV Technologies SA
  • F. Hoffmann-La Roche Ltd
  • MORE
Peanut Allergy Global Clinical Trials Review, H1, 2020

Summary

This clinical trial report, “Peanut Allergy Global Clinical Trials Review, H1, 2020" provides an overview of Peanut Allergy Clinical trials scenario. This report provides top line data relating to the clinical trials on Peanut Allergy. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. The clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aimmune Therapeutics Inc
  • AnaptysBio Inc
  • Aravax Pty Ltd
  • Astellas Pharma Inc
  • DBV Technologies SA
  • F. Hoffmann-La Roche Ltd
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Peanut Allergy to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Peanut Allergy Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Peanut Allergy
  • Nov 14, 2019: Antibody injection stops peanut allergy for 2 to 6 weeks, Stanford-led study shows
  • Nov 08, 2019: AR101 demonstrates consistent efficacy and safety in new analysis at ACAAI comparing PALISADE and ARTEMIS phase 3 clinical data
  • Nov 08, 2019: New data presented at ACAAI 2019 show importance of clinical history in identifying AR101-eligibile patients for PALISADE study without a food challenge
  • Nov 07, 2019: POISED study supports risk of cessation of oral immunotherapy for peanut allergy; PACE study indicates safer peanut allergy treatment approaches are needed
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Publisher
  • Contact Us
  • Source
List of Tables
  • Peanut Allergy Therapeutics, Global, Clinical Trials by Region, 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Proportion of Peanut Allergy to Immunology Clinical Trials, G7 Countries (%), 2020*
  • Peanut Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Peanut Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Peanut Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
List of Figures
  • Peanut Allergy Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Peanut Allergy Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Proportion of Peanut Allergy to Immunology Clinical Trials, G7 Countries (%), 2020*
  • Peanut Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Peanut Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Peanut Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Peanut Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Peanut Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • Report Methodology
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aimmune Therapeutics Inc
  • DBV Technologies SA
  • F. Hoffmann-La Roche Ltd
  • AnaptysBio Inc
  • Food Allergy Research & Education Inc
  • Novartis AG
  • Sanofi
  • Aravax Pty Ltd
  • Astellas Pharma Inc
  • Droege International Group AG
Note: Product cover images may vary from those shown
Adroll
adroll